Saving Mothers' Lives: - Public Health Agency for Northern Ireland
Saving Mothers' Lives: - Public Health Agency for Northern Ireland
Saving Mothers' Lives: - Public Health Agency for Northern Ireland
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Pulmonary embolism<br />
Of the 33 women who died from pulmonary embolism, ten died during the fi rst trimester of their pregnancy<br />
and one during the second trimester. A further three women died antenatally; two following terminations<br />
of pregnancy and one following an ectopic pregnancy. An additional four women who collapsed in late<br />
pregnancy from a pulmonary embolism were delivered by a peri or post mortem caesarean section; these<br />
are also classifi ed as antepartum deaths. No women died during labour. In all, fi fteen women died in the<br />
postpartum period, eight following a vaginal delivery and seven after a caesarean section.<br />
The women who died<br />
Risk factors <strong>for</strong> thromboembolism were identifi able in 26 of the 33 women. Sixteen were overweight and<br />
four women had a past or family history of venous thromboembolism (VTE). Two died after air travel in<br />
pregnancy, one had hyperemesis gravidarum and one had ovarian hyperstimulation syndrome (OHSS).<br />
Three women had a history of surgery unrelated to pregnancy and one underwent craniotomy in the<br />
puerperium. Seven had no recorded risk factors but in four of these cases details were inadequate.<br />
Of the 21 women whose pregnancies exceeded 12 weeks’ gestation, four did not attend <strong>for</strong> regular antenatal<br />
care. In one case, an asylum seeker saw her General Practitioner early in pregnancy but did not receive<br />
a booking appointment until after fi ve months had elapsed. The other three women had complex lives and<br />
were known to either be substance misusers, have child protection issues, or both. Six of the 21 women were<br />
Black African or Caribbean and two were South Asian. Three women could not speak English.<br />
Risk factors<br />
Weight<br />
The National Institute <strong>for</strong> Clinical Excellence (NICE) guideline on antenatal care recommends that every<br />
woman should have her BMI checked at the fi rst antenatal visit and that women with a BMI over 35 are not<br />
suitable <strong>for</strong> routine midwifery led care2 . The mother’s weight was recorded in only 25 cases and the BMI<br />
could be calculated <strong>for</strong> only 21. Of these, sixteen were overweight, with a BMI of over 25. Twelve of these<br />
were classifi ed as obese with a BMI over 30, including eight who were morbidly obese with a BMI over 35.<br />
The latter included two who died after caesarean section. The highest reported BMI was 62, and another<br />
fi ve women had BMIs over 40. Two of the morbidly obese women inappropriately had midwife-only care.<br />
Two of the three women who suffered a Late Direct death from pulmonary embolism were also obese or<br />
morbidly obese.<br />
Women with a BMI of 40 or above are at a high risk of VTE but current RCOG guidelines 3, 4, 5 recommend<br />
the same prophylactic doses of low molecular weight heparin (LMWH) <strong>for</strong> all women with a BMI over<br />
30 or a weight exceeding 90Kg. The RCOG guideline on thromboprophylaxis during pregnancy, labour<br />
and after normal vaginal delivery 2 recommends that “one or two risk factors alone may be suffi cient to<br />
justify antenatal thromboprophylaxis with LMWH, <strong>for</strong> example an extremely obese woman admitted to<br />
the antenatal ward.” This advice relies on clinical judgement and was rein<strong>for</strong>ced in the last Report, but<br />
of the eight morbidly obese women whose deaths are discussed in the present Report, six received no<br />
thromboprophylaxis, one received an inadequate dosage and one received the correct dose but not until<br />
some time after her caesarean section. A specifi c guideline is now required on thromboprophylaxis <strong>for</strong><br />
morbidly obese women.<br />
57